Here is What Hedge Funds Think About Ariad Pharmaceuticals, Inc. (ARIA)

Page 1 of 2

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shareholders have witnessed an increase in activity from the world’s largest hedge funds of late.

To the average investor, there are a multitude of indicators market participants can use to watch publicly traded companies. A pair of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best investment managers can trounce the broader indices by a solid margin (see just how much).

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)Equally as integral, positive insider trading sentiment is a second way to parse down the investments you’re interested in. As the old adage goes: there are lots of motivations for a corporate insider to drop shares of his or her company, but only one, very clear reason why they would behave bullishly. Several academic studies have demonstrated the valuable potential of this strategy if investors know where to look (learn more here).

With these “truths” under our belt, let’s take a gander at the recent action regarding Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).

What have hedge funds been doing with Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)?

At the end of the first quarter, a total of 30 of the hedge funds we track held long positions in this stock, a change of 36% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists a few noteworthy hedge fund managers who were upping their stakes significantly.

Of the funds we track, Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management had the biggest position in Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), worth close to $73.8 million, accounting for 2.3% of its total 13F portfolio. The second largest stake is held by Dan Loeb of Third Point, with a $49.7 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Phill Gross and Robert Atchinson’s Adage Capital Management, Julian Baker and Felix Baker’s Baker Bros. Advisors and Donald Chiboucis’s Columbus Circle Investors.

As one would reasonably expect, some big names were breaking ground themselves. Millennium Management, managed by Israel Englander, initiated the biggest position in Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). Millennium Management had 10.7 million invested in the company at the end of the quarter. James E. Flynn’s Deerfield Management also initiated a $5.5 million position during the quarter. The other funds with brand new ARIA positions are Glenn Russell Dubin’s Highbridge Capital Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Louis Bacon’s Moore Global Investments.

How have insiders been trading Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)?

Insider trading activity, especially when it’s bullish, is best served when the company in focus has experienced transactions within the past half-year. Over the last half-year time period, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has experienced zero unique insiders buying, and 11 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). These stocks are Theravance Inc (NASDAQ:THRX), Seattle Genetics, Inc. (NASDAQ:SGEN), Incyte Corporation (NASDAQ:INCY), Medivation Inc (NASDAQ:MDVN), and Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). This group of stocks are the members of the biotechnology industry and their market caps are similar to ARIA’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!